Osteoporosis Treatment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Osteoporosis Treatment Market

The Osteoporosis Treatment market size was valued at USD 10.75 billion in 2018, and the market is now projected tgrow from USD 10.75 billion in 2018 tUSD 19.68 billion by 2032, exhibiting a CAGR of 4.4% during the forecast period of 2019-2032.

The COVID-19 pandemic significantly impacted the Osteoporosis Treatment market growth, mostly due tdisruptions in healthcare services and decreased affected person visits thospitals and clinics. Lockdowns and resource reallocation tmanipulate COVID-19 instances caused not on-time diagnoses and treatment initiation for osteoporosis patients. Clinical trials for new treatments had alsbeen postponed, hindering the development pipeline. However, the increasing adoption of telemedicine and digital health platforms facilitated patient consultations and medicinal drug adherence, partly mitigating the poor outcomes. As the healthcare machine stabilised post-pandemic, the marketplace began recuperating, driven by a renewed recognition of addressing not on-time treatments and the developing cognisance of osteoporosis management.

Osteoporosis capsules are especially used as the remedy for sufferers tormented by osteoporosis, a couple of fractures, geriatric people suffering from osteoarthritis, and ladies suffering from postmenopausal disorders. An upward push in awareness about sickness and remedy alternatives has encouraged the adoption of osteoporosis treatment across the globe and increased the Osteoporosis Treatment market share. Therefore, the adoption of the osteoporosis treatment has prompted the producers timprove the brand-new product, which includes EVENITY, using Amgen, Inc. The product obtained approvals from the USFDA, the European Commission and The Japanese Ministry of Health, Labor and Welfare (MHLW) in 2019.

Additionally, growing technological advances have resulted in the creation of recent efficient diagnostic answers for screening osteoporosis. For instance, the release of an index via BONE INDEX FINLAND LTD is used for osteoporosis diagnostics with worldwide tips. The accuracy, simplicity of utilisation, and quickness of this tool help in excessive quantity threat group screening.

Comprehensive Analysis of the Osteoporosis Treatment Market

The osteoporosis drug marketplace is segmented by drug class, route of administration, and distribution channel. Bisphosphonates dominate the drug elegance segment as the first-line treatment, reducing bone loss and enhancing bone density, with examples like Fosamax, Actonel, and Reclast showcasing varying dosing frequencies. Parenteral administration leads the market because of its full-size sales share and growing adoption, while oral administration is predicted tdevelop with the creation of extra convenient biosimilars. In terms of distribution channels, sanatorium pharmacies’ power boom through improved affected person visits and authorities help, even as retail pharmacies gain from partnerships with orthopaedic and girls’ fitness facilities. Additionally, online pharmacies are gaining traction due tthe ease of online drug purchases and producers' awareness of increasing virtual distribution channels.

The international osteoporosis capsules marketplace in North America accounted for USD 4.72 billion in 2018. The North American marketplace is predicted tdominate the osteoporosis remedy market. The dominance of the place is classed by using a rise in the incidence of osteoporosis conditions.

AbbVie Inc. (North Chicago, Illinois), Eli Lilly and Company (Indianapolis, Indiana), Amgen Inc. (Thousand Oaks, California), F. Hoffmann-La Roche Ltd (Basel, Switzerland), Novartis AG (Basel, Switzerland), Sanofi (Paris, France), and Pfizer Inc. (New York, New York) are key players inside the pharmaceutical industry, every contributing extensively tadvancements inside the treatment of various health situations, together with osteoporosis.

In August 2019 – The biosimilar teriparatide biosimilar named terrorism by GEDEON Richter was released in Europe after the patent expiry for its reference product. This product is indicated for the treatment of osteoporosis in postmenopausal girls and in men with a high danger of fracture on the side of osteoporosis-related tsustained systemic glucocorticoid therapy in women and men at multiplied threat of fracture.

Segmentation Table

Global Osteoporosis Treatment Market Scope

Study Period 2015-2026

Base Year 2018

Forecast Period 2019-2026

Growth Rate CAGR of 4.4% from 2024-2032

Historical Period 2015-2017

Unit Value (USD Billion)

Segmentation By drug class, route of administration, distribution channel, and Region

By drug class

• Bisphosphonate
• Hormone Replacement Therapy
• Selective Estrogen Receptor Modulator (SERMs)
• RANK ligand (RANKL) Inhibitor
• Others

By route of administration

• Oral
• Parenteral

By distribution channel

• Hospitals Pharmacies
• Retail Pharmacies & Stores
• Online Pharmacies

By Region

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Please Note: It will take 5-6 business days to complete the report upon order confirmation.